PLMR Q1 2026 Earnings EPS Surpasses Estimates by 301 Amid Modest Stock Pullback Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage RDZN Q1 2026 Earnings Significant EPS Miss Highlights Ongoing Challenges CEVA Q1 2026 Earnings EPS Surprise Drives Positive Market Response AWK Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain ILPT Q1 2026 Earnings Earnings Beat Driven by Cost Management Shares Edge Lower